Dried Flower |
| |||
649 of 777 products in Dried Flower |
THC | 190 - 260mg/g (~22.5%) | VERY STRONG | 0 - 10mg/g (~0.5%) | CBD |
eweed.pro | SATIVA | csmeter © |
2.5 ★★ (10)★ ☆ ☆☆ |
~$8.05 /g * |
ADD
$9.03 1g $9.03/g |
ADD
$27.39 3.5g $7.83/g |
ADD
$50.97 7g $7.28/g |
Pepper |
AROMA / FLVR |
||
+Pine | +Woody |
Inflammation |
AID** WITH |
||
+Relaxation | +Antiseptic |
Potency | Very Strong | |
THC | 190 - 260mg/g | (19% - 26%) |
CBD | 0 - 10mg/g | (0% - 1%) |
Plant Type | Sativa Dominant | |
Strain(s) | Apple Pie | |
Grown In | Southern Ontario | |
Method | HYBRID-GREENHOUSE | |
Producer | Tokyo Smoke by Canopy Growth Corp. | |
GTIN# | 00886708000111 (1g) 00886708000128 (3.5g) 00886708000135 (7g) |
|
Terpenes | Beta-Pinene, Beta-Caryophyllene, Terpineol, Trans-Caryophyllene |
Go dried flower by Tokyo Smoke is a hang-dried sativa-dominant strain with very strong THC potency and a terpene profile that includes beta-pinene, beta- and trans-caryophyllene, and terpineol, which produce floral and citrus notes, and hints of spice. Grown in a hybrid greenhouse, its dense flowers are light green with orange and gold tones. Available pre-rolled and in various dried flower sizes.
Tokyo Smoke is an award-winning, design-focused company that seamlessly blends the best of cannabis with preeminent retail. Tokyo Smoke is ushering in a new era with an elevated and immersive retail experience featuring it’s signature collection of accessories and line of recreational cannabis.
About Canopy Growth
Our vision is to be the number one cannabis company in the world. From product and process innovation to market execution and everything in between, we are driven by a passion for leadership, a commitment to drive the industry forward, and above all else, providing medical and recreational cannabis consumers the best possible experience.
With operations spanning fifteen countries across five continents, Canopy Growth Corporation is a world-leading diversified cannabis company proudly dedicated to educating healthcare practitioners, advancing the public discourse surrounding cannabis, and conducting robust clinical research in cannabinoid-based animal and human medicines.